Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06067685 · ClinicalTrials.gov registry record
Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
A clinical trial, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- 7
- Enrollment target
NCT06067685: Clinical Trial study, sponsored by University of Kansas Medical Center.
NCT06067685 is a clinical trial that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06067685 was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is a prospective, observational study which examines the association between maternal triglycerides in the antepartum period and fetal overgrowth in pregnancies complicated by gestational diabetes. Mothers are asked to provide 2 blood samples, undergo fingerstick blood measurements, and to have their newborns measured for body fat composition in the first 6 months of life.
Primary Outcome
Correlation coefficient
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-08-10 |
| Est. Completion | 2024-09-01 |
Why NCT06067685 stopped before completion
NCT06067685 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT06067685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06067685 about?
NCT06067685 is a clinical study titled "Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes". This is a prospective, observational study which examines the association between maternal triglycerides in the antepartum period and fetal overgrowth in pregnancies complicated by gestational diabetes. Mothers are asked to provide 2 blood samples, undergo fingerstick blood measurements, and to have...
What is the current status of trial NCT06067685?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2023-08-10. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT06067685?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT06067685?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI